Cargando…

Cost-effectiveness of routine measuring of serum drug concentrations and anti-drug antibodies in treatment of rheumatoid arthritis patients with TNF-α blockers

Monitoring of anti-drug antibodies (ADAbs) or serum concentrations of biologicals in treatment of rheumatoid arthritis could provide an explanation for a loss of efficacy and help in the choice of subsequent medication. Current clinical practices do not generally include such monitoring of tumor nec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laine, Juha, Jokiranta, T Sakari, Eklund, Kari K, Väkeväinen, Merja, Puolakka, Kari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824281/ https://www.ncbi.nlm.nih.gov/pubmed/27099470 http://dx.doi.org/10.2147/BTT.S96982

Ejemplares similares

Cost-effectiveness of abatacept, tocilizumab and TNF-inhibitors compared with rituximab as second-line biologic drug in rheumatoid arthritis
por: Huoponen, Saara, et al.
Publicado: (2019)

Cost–utility of different treatment strategies after the failure of tumour necrosis factor inhibitor in rheumatoid arthritis in the Finnish setting
por: Hallinen, Taru A., et al.
Publicado: (2010)

Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study
por: Paalanen, Kirsi, et al.
Publicado: (2020)

Erratum to: Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study
por: Paalanen, Kirsi, et al.
Publicado: (2021)

First-year drug therapy of new-onset rheumatoid and undifferentiated arthritis: a nationwide register-based study
por: Muilu, Paula, et al.
Publicado: (2020)

Sustainability of TNF-blocker tapering in rheumatoid arthritis over 3 years: long-term follow-up of the STRASS (Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study) randomised controlled trial
por: Sigaux, Johanna, et al.
Publicado: (2017)

Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial
por: Rantalaiho, Vappu, et al.
Publicado: (2010)

Etanercept for patients with juvenile idiopathic arthritis: drug levels and influence of concomitant methotrexate: observational study
por: Levälampi, Tiina, et al.
Publicado: (2023)

Cost Effectiveness of TNF-α Inhibitors in Rheumatoid Arthritis
por: Said, Cynthia, et al.
Publicado: (2013)

Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis
por: Cho, Soo-Kyung, et al.
Publicado: (2016)

Cost-effectiveness analysis of secukinumab versus other biologics and apremilast in the treatment of active Psoriatic arthritis: a Finnish perspective
por: Purmonen, Timo, et al.
Publicado: (2018)

Restored and Enhanced Memory T Cell Immunity in Rheumatoid Arthritis After TNFα Blocker Treatment
por: Khanniche, Asma, et al.
Publicado: (2019)

Modeled Health Economic Impact of a Hypothetical Certolizumab Pegol Risk-Sharing Scheme for Patients with Moderate-to-Severe Rheumatoid Arthritis in Finland
por: Soini, Erkki, et al.
Publicado: (2017)

Administration costs of intravenous biologic drugs for rheumatoid arthritis
por: Soini, Erkki J, et al.
Publicado: (2013)

Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNFα blocker failure
por: Kekow, Joern, et al.
Publicado: (2012)

Influence of Immunogenicity on the Efficacy of Long-Term Treatment with TNFα Blockers in Rheumatoid Arthritis and Spondyloarthritis Patients
por: Arstikyte, Inesa, et al.
Publicado: (2015)

Rheumatoid Meningoencephalitis: A Feared Condition in the Era of TNF Blockers
por: Figueroa Rodriguez, Fernando, et al.
Publicado: (2018)

Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab
por: Neovius, M, et al.
Publicado: (2015)

T-Cell Subsets in Rheumatoid Arthritis Patients on Long-Term Anti-TNF or IL-6 Receptor Blocker Therapy
por: Dulic, Sonja, et al.
Publicado: (2017)

Deletion at 2q14.3 is associated with worse response to TNF-α blockers in patients with rheumatoid arthritis
por: Gu, Ki-Nam, et al.
Publicado: (2019)

Cost-Effectiveness Modelling of Sequential Biologic Strategies for the Treatment of Moderate to Severe Rheumatoid Arthritis in Finland
por: Puolakka, K, et al.
Publicado: (2012)

Rheumatoid factor as predictor of response to treatment with anti-TNF alpha drugs in patients with rheumatoid arthritis: Results of a cohort study
por: Santos-Moreno, Pedro, et al.
Publicado: (2019)

Psychiatric disorders in incident patients with juvenile idiopathic arthritis - a case-control cohort study
por: Kyllönen, Minna S., et al.
Publicado: (2021)

Cost of tumor necrosis factor blockers per patient with rheumatoid arthritis in a multistate Medicaid population
por: Bonafede, Machaon, et al.
Publicado: (2014)

Cost-effectiveness of secukinumab compared to other biologics in the treatment of ankylosing spondylitis in Finland
por: Purmonen, Timo, et al.
Publicado: (2019)

Assessing the Need for Multiplex and Multifunctional Tick-Borne Disease Test in Routine Clinical Laboratory Samples from Lyme Disease and Febrile Patients with a History of a Tick Bite
por: Garg, Kunal, et al.
Publicado: (2021)

Low Serum BAFF Concentration Is Associated with Response to TNF Inhibitors in Seropositive Patients with Rheumatoid Arthritis
por: Hernández-Breijo, Borja, et al.
Publicado: (2022)

Bone and TNF in rheumatoid arthritis: clinical implications
por: Manara, Maria, et al.
Publicado: (2015)

The use of TNF-α blockers in psoriatic arthritis patients with latent tuberculosis infection
por: Atteno, Mariangela, et al.
Publicado: (2014)

Clinical Utility and Cost Savings in Predicting Inadequate Response to Anti-TNF Therapies in Rheumatoid Arthritis
por: Bergman, Martin J., et al.
Publicado: (2020)

TNF-α Blockers Showed Prophylactic Effects in Preventing COVID-19 in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthropathies: A Case–Control Study
por: Salesi, Mansour, et al.
Publicado: (2021)

TNF-α and TNF-β Gene Polymorphism in Saudi Rheumatoid Arthritis Patients
por: Al-Rayes, Hannan, et al.
Publicado: (2011)

The Effect of TNF and Non-TNF-Targeted Biologics on Body Composition in Rheumatoid Arthritis
por: Vial, Gaelle, et al.
Publicado: (2021)

Noninvasive imaging methods for evaluating cardiovascular involvement in patients with rheumatoid arthritis before and after anti-TNF drug treatment
por: Atzeni, Fabiola, et al.
Publicado: (2019)

Predicting treatment response to IL6R blockers in rheumatoid arthritis
por: Nouri, Bako, et al.
Publicado: (2020)

Bone Effects of Biologic Drugs in Rheumatoid Arthritis
por: Corrado, Addolorata, et al.
Publicado: (2013)

Drug-related problems in patients with rheumatoid arthritis
por: Ma, Shu Ning, et al.
Publicado: (2019)

Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis
por: Convertino, Irma, et al.
Publicado: (2023)

Cost-utility of routine cataract surgery
por: Räsänen, Pirjo, et al.
Publicado: (2006)

Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in MUC5B mutation carriers
por: Palomäki, Antti, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lasp08r5b75haa3t44f7v6ar3b